Neuropathy Patients More Likely to Receive High-cost, Low-yield Screening Instead of More Effective Tests

A new study from University of Michigan researchers found that the most efficient testing is not always done for peripheral neuropathy – especially diabetes related neuropathy. Led by Dr. Brian Callaghan, Assistant Professor of Neurology, the team found that many tests can be given but physicians are highly variable in approach. There is a lot of money spent testing for peripheral neuropathy but the researchers feel that money is not always well spent. READ MORE from University of Michigan or READ MORE from US News.

Source: University of Michigan, US News and World Report

Send this to a friend